Adam Hansen is the CEO and founder of Geneial, a private exchange for biomedical data. He is dedicated to helping relieve human suffering by accelerating precision medicine, and Geneial envisions a world where diagnostics and treatments are available for every disorder in every population. Adam received a PhD in computational genetics at Baylor College of Medicine under Dr. Richard Gibbs, a leader of the Human Genome Project, and led the discovery of more than 150 candidate genetic disorders. He has received >$2M in NIH grant funding, and was formerly a biodesign fellow at the Texas Medical Center Innovation Institute.